Is the pharma gender gap starting to close?When Emma Walmsley took the reins of GlaxoSmithKline (GSK) in 2016, becoming the first woman to head up Share XIs the pharma gender gap starting to close?https://pharmaphorum.com/views-analysis-sales-marketing/is-the-pharma-gender-gap-starting-to-close/
AstraZeneca may have hit rock bottom, but can it rise to new heights?Back in 2014, Pascal Soriot CEO of AstraZeneca managed to stave off a takeover bid from Pfizer with Share XAstraZeneca may have hit rock bottom, but can it rise to new heights?https://pharmaphorum.com/views-analysis-sales-marketing/astrazeneca-rise-new-heights/
Brand planning in complex and uncertain marketsIn our first article we addressed the modern challenges to strategic planning; the growing complexity and uncertainty that Share XBrand planning in complex and uncertain marketshttps://pharmaphorum.com/views-analysis-sales-marketing/brand-planning-in-complex-and-uncertain-markets/
Are dual ARVs the new frontier in a maturing HIV market?Tackling and managing HIV has been one of the pharmaceutical industry’s more distinguished achievements, despite the turbulence and Share XAre dual ARVs the new frontier in a maturing HIV market?https://pharmaphorum.com/sales-marketing/are-dual-arvs-the-new-frontier-in-a-maturing-hiv-market/
Strategic planning in increasingly complex and uncertain markets, the David Cassidy dilemmaThis article is the first in a series of three from Osprey Health Consulting that address the contemporary Share XStrategic planning in increasingly complex and uncertain markets, the David Cassidy dilemmahttps://pharmaphorum.com/views-analysis-sales-marketing/strategic-planning-increasingly-complex-uncertain-markets/
The future biosimilar landscape: the pharmaphorum podcastFor episode 3 of the pharmaphorum podcast Dominic Tyer went to the UK headquarters of Sandoz to meet Share XThe future biosimilar landscape: the pharmaphorum podcasthttps://pharmaphorum.com/sales-marketing/the-future-biosimilar-landscape/
Nimble consumer healthcare innovation: the pharmaphorum podcastIn episode 2 of the podcast pharmaphorum talked to the CEO of Infirst Healthcare Manfred Scheske about how Share XNimble consumer healthcare innovation: the pharmaphorum podcasthttps://pharmaphorum.com/views-analysis-sales-marketing/consumer-healthcare-innovation/
Communication problems holding back new cancer treatments Cancer immunotherapy is revolutionising oncology – but the Havas Lynx Group’s chief medical officer Vernon Bainton argues that the incredible progress is Share XCommunication problems holding back new cancer treatments https://pharmaphorum.com/oncology/communication-problems-holding-back-new-cancer-treatments/
Collaborative working is key for the NHS and pharmaBoth the NHS and pharma recognise the need and the opportunity to collaborate in order to improve patient Share XCollaborative working is key for the NHS and pharmahttps://pharmaphorum.com/views-and-analysis/collaborative-working-key-nhs-pharma/
